Dwayne L. Lashyn

Director/Board Member at Ethicann Pharmaceuticals, Inc.

58 year

Health Technology

Profile

Dwayne L.
Lashyn is currently working as the Managing Director & Vice President at Quantico Capital Corp.
and as a Director at Ethicann Pharmaceuticals, Inc. He previously worked as an Independent Director at CanniMed Therapeutics, Inc. from 2004 to 2018.

Dwayne L. Lashyn active positions

Companies	Position	Start
Quantico Capital Corp.	Corporate Officer/Principal	01/06/1992
Ethicann Pharmaceuticals, Inc. Ethicann Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ethicann Pharmaceuticals, Inc. manufactures pharmaceutical products. It focuses on the commercialization of cannabis-based ethical drugs. The company was founded by Brandon J. Price in 2018 and is headquartered in Toronto, Canada.	Director/Board Member	-

All active positions of Dwayne L. Lashyn

Former positions of Dwayne L. Lashyn

Companies	Position	End
CANNIMED THERAPEUTICS INC	Director/Board Member	15/03/2018

See the detail of Dwayne L. Lashyn's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dwayne L. Lashyn's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Quantico Capital Corp.
CanniMed Therapeutics, Inc. CanniMed Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology CanniMed Therapeutics, Inc. operated as a biopharmaceutical company. It offered plant biotechnology research and product development programs. The firm focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. The company was founded on Oct 31st, 2016 and was headquartered in Saskatoon, Canada.	Health Technology
Ethicann Pharmaceuticals, Inc. Ethicann Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ethicann Pharmaceuticals, Inc. manufactures pharmaceutical products. It focuses on the commercialization of cannabis-based ethical drugs. The company was founded by Brandon J. Price in 2018 and is headquartered in Toronto, Canada.	Health Technology

See company connections

Stock Market
Insiders
Dwayne L. Lashyn